TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA)

36.36USD -0.71% (-0.26)

Over 1M: +2.8%

Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles and bars need the day’s open, high and low, and need room to be drawn in: past about a year of trading a body is thinner than a hairline, so those three offer the longest window that fits instead.

36 37 38
7 Aug 12 Aug 17 Aug 20 Aug 25 Aug 28 Aug 2 Sep

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '21 — Revenue: 3.9B Q3 '21 — Gross Profit: 1.8B Q4 '21 — Revenue: 4.1B Q4 '21 — Gross Profit: 2B Q1 '22 — Revenue: 3.7B Q1 '22 — Gross Profit: 1.7B Q2 '22 — Revenue: 3.8B Q2 '22 — Gross Profit: 1.8B Q3 '22 — Revenue: 3.6B Q3 '22 — Gross Profit: 1.7B Q4 '22 — Revenue: 3.9B Q4 '22 — Gross Profit: 1.8B Q1 '23 — Revenue: 3.7B Q1 '23 — Gross Profit: 1.6B Q2 '23 — Revenue: 3.9B Q2 '23 — Gross Profit: 1.8B Q3 '23 — Revenue: 3.9B Q3 '23 — Gross Profit: 1.9B Q4 '23 — Revenue: 4.5B Q4 '23 — Gross Profit: 2.4B Q1 '24 — Revenue: 3.8B Q1 '24 — Gross Profit: 1.8B Q2 '24 — Revenue: 4.2B Q2 '24 — Gross Profit: 2B Q3 '24 — Revenue: 4.3B Q3 '24 — Gross Profit: 2.1B Q4 '24 — Revenue: 4.2B Q4 '24 — Gross Profit: 2.1B Q1 '25 — Revenue: 3.9B Q1 '25 — Gross Profit: 1.9B Q2 '25 — Revenue: 4.2B Q2 '25 — Gross Profit: 2.1B Q3 '25 — Revenue: 4.5B Q3 '25 — Gross Profit: 2.3B Q4 '25 — Revenue: 4.7B Q4 '25 — Gross Profit: 2.7B Q1 '26 — Revenue: 4B Q1 '26 — Gross Profit: 2B Q2 '26 — Revenue: 4.1B Q2 '26 — Gross Profit: 2.2B 0 1B 2B 3B 4B 5B
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Gross Profit

How it scores

For a valuation multiple, the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

4.2
SBC / sales 0.97%
OE margin 6.8%
ROIC 14.8%
Accruals -3.0%
Gross margin 52.5%
FCF margin 7.8%
OCF / EBIT 1.2×
OCF margin 11.0%
ROA 1.8%
ROCE 6.6%
ROE 9.1%

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

5.9
EV/EBIT 27.0×
EV/OE 36.7×
EV/GP 4.8×
EV/Sales 2.5×
P/C 11.5×
FCF yield 3.2%
P/B 5.5×
P/E 60.2×
Div. yield —
Fwd P/E —
PEG —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

6.7
Segment HHI 0.61 HHI
RPO / sales —
RPO growth —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

3.3
ND/EBITDA -0.019
Current ratio 0.88×
Debt payback 0.6 yr
F-score 7.9 pts
Payout 0.0%
Cash / Debt 0.82×
Debt / Eq 0.58×
Quick ratio 0.67×
Cash runway —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

4.9
Sales/sh Y/Y +1.3%
EBIT Y/Y +79.3%
EPS CAGR 4Y +33.6%
Div. growth -98.7%
Sales Q/Q -0.81%
EBIT CAGR —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.